Results 121 to 130 of about 1,211 (133)
Cardiac Markers in Pediatric Laboratory Medicine: Critical Review. [PDF]
Zrinski Topic R, Lenicek Krleza J.
europepmc +1 more source
The STING pathway drives noninflammatory neurodegeneration in NGLY1 deficiency. [PDF]
Yang K +15 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acute liver failure in a male patient with NGLY1-congenital disorder of deglycosylation
European Journal of Medical Genetics, 2020Congenital disorder of N-linked deglycosylation (CDDG, MIM 615273) is a very rare autosomal recessive disorder caused by pathogenic variants in the NGLY1 gene. Transient transaminitis is the typical hepatic dysfunction described in these patients, but also included neonatal jaundice, hepatomegaly, splenomegaly, and steatosis.
Izabel Maryalexandra, Rios-Flores +10 more
openaire +4 more sources
Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation
Molecular Genetics and Metabolism, 2019NGLY1-CDDG is a congenital disorder of deglycosylation caused by a defective peptide:N-glycanase (PNG). To date, all but one of the reported patients have been diagnosed through whole-exome or whole-genome sequencing, as no biochemical marker was available to identify this disease in patients.
Haijes, Hanneke A. +12 more
openaire +6 more sources
PROTEOMICS, 2005
AbstractA general strategy for the structural evaluation of N‐glycosylation, a common post‐translational protein modification, is presented. The methods for the release of N‐linked glycans from the gel‐separated proteins, their isolation, purification and matrix‐assisted laser desorption/ionisation‐mass spectrometry (MALDI‐MS) analysis of their ...
Dijana, Sagi +4 more
openaire +2 more sources
AbstractA general strategy for the structural evaluation of N‐glycosylation, a common post‐translational protein modification, is presented. The methods for the release of N‐linked glycans from the gel‐separated proteins, their isolation, purification and matrix‐assisted laser desorption/ionisation‐mass spectrometry (MALDI‐MS) analysis of their ...
Dijana, Sagi +4 more
openaire +2 more sources
Advanced therapeutics
There are many neurological rare diseases where animal models have proven inadequate or do not currently exist. NGLY1 Deficiency, a congenital disorder of deglycosylation, is a rare disease that predominantly affects motor control, especially control of neuromuscular action. In this study, NGLY1-deficient, patient-derived induced pluripotent stem cells
Trevor, Sasserath +15 more
openaire +1 more source
There are many neurological rare diseases where animal models have proven inadequate or do not currently exist. NGLY1 Deficiency, a congenital disorder of deglycosylation, is a rare disease that predominantly affects motor control, especially control of neuromuscular action. In this study, NGLY1-deficient, patient-derived induced pluripotent stem cells
Trevor, Sasserath +15 more
openaire +1 more source
The changing epidemiology of congenital heart disease
Nature Reviews Cardiology, 2010Aeilko H Zwinderman, Berto Bouma
exaly

